Science
Mechanism of Action
Upon topical application, Thurfyl Nicotinate undergoes hydrolysis within the skin, releasing nicotinic acid (Vitamin B3). This liberated nicotinic acid acts as a potent peripheral vasodilator, leading to a noticeable increase in cutaneous blood flow and a characteristic flushing response. The induced inflammatory reaction, manifesting as erythema and wealing, is partially mediated by prostaglandin-like activity and a localized suppression of fibrinolysis.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Topical application in humans consistently induces erythema and wealing (cutaneous reactions).
- 02 Flushing responses are observed in guinea-pigs following topical application.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This ester exhibits optimal stability in acidic to slightly neutral pH environments, specifically within a range of 2.0 to 7.0. Degradation due to hydrolysis significantly accelerates under alkaline conditions.
Conflicts
- strong oxidizing agents
- strong bases
- amines
- strong reducing agents
- highly alkaline excipients
Safety
Safety Profile
Comprehensive safety assessments by regulatory bodies such as CIR (Cosmetic Ingredient Review) or SCCS (Scientific Committee on Consumer Safety) are not available for Thurfyl Nicotinate. The ingredient is known to induce significant cutaneous reactions and flushing, indicating a high potential for irritation, particularly in individuals with sensitive skin. Furthermore, chemically related compounds like Tetrahydrofurfuryl alcohol are identified as skin and eye irritants, and a suspected reproductive toxicant by ANSES.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Given its high potential for inducing significant skin irritation and the absence of comprehensive safety reviews from cosmetic regulatory bodies, Thurfyl Nicotinate is not recommended for precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…